Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
2.

Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer Database.

Uhlig J, Sellers CM, Cha C, Khan SA, Lacy J, Stein SM, Kim HS.

Ann Surg Oncol. 2019 Jan 28. doi: 10.1245/s10434-019-07175-4. [Epub ahead of print]

PMID:
30693451
3.

Regional Differences in Palliative Care Utilization Among Geriatric Colorectal Cancer Patients Needing Emergent Surgery.

Heller DR, Jean RA, Chiu AS, Feder SI, Kurbatov V, Cha C, Khan SA.

J Gastrointest Surg. 2019 Jan;23(1):153-162. doi: 10.1007/s11605-018-3929-0. Epub 2018 Sep 4.

PMID:
30328071
4.

Clinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma.

Zhu R, Liu F, Grisotti G, Perez-Irizarry J, Salem RR, Cha CH, Johung KL, Boffa DJ, Zhang Y, Khan SA.

J Gastrointest Oncol. 2018 Jun;9(3):517-526. doi: 10.21037/jgo.2018.03.05.

5.

Distinctive features of gastrointestinal stromal tumors arising from the colon and rectum.

Zhu R, Liu F, Grisotti G, Pérez-Irizarry J, Cha CH, Johnson CH, Boffa DJ, Han D, Johung KL, Zhang Y, Khan SA.

J Gastrointest Oncol. 2018 Apr;9(2):231-240. doi: 10.21037/jgo.2017.11.12.

6.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S.

J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.

PMID:
28784865
7.

Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination.

Vilarinho S, Erson-Omay EZ, Mitchell-Richards K, Cha C, Nelson-Williams C, Harmancı AS, Yasuno K, Günel M, Taddei TH.

J Hepatol. 2017 Jul;67(1):186-191. doi: 10.1016/j.jhep.2017.03.009. Epub 2017 Mar 18.

8.

Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism.

Hollander L, Guo X, Velazquez H, Chang J, Safirstein R, Kluger H, Cha C, Desir GV.

Cancer Res. 2016 Jul 1;76(13):3884-94. doi: 10.1158/0008-5472.CAN-15-1524. Epub 2016 May 9.

9.

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.

Stein SM, James ES, Deng Y, Cong X, Kortmansky JS, Li J, Staugaard C, Indukala D, Boustani AM, Patel V, Cha CH, Salem RR, Chang B, Hochster HS, Lacy J.

Br J Cancer. 2016 Mar 29;114(7):737-43. doi: 10.1038/bjc.2016.45.

10.

Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer.

Guo X, Hollander L, MacPherson D, Wang L, Velazquez H, Chang J, Safirstein R, Cha C, Gorelick F, Desir GV.

Sci Rep. 2016 Mar 14;6:22996. doi: 10.1038/srep22996.

11.

The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma.

Hollander LL, Guo X, Salem RR, Cha CH.

J Surg Res. 2015 Aug;197(2):219-24. doi: 10.1016/j.jss.2014.11.002. Epub 2015 Apr 20.

PMID:
25982376
12.

Resection of oligometastatic lung cancer to the pancreas may yield a survival benefit in select patients--a systematic review.

DeLuzio MR, Moores C, Dhamija A, Wang Z, Cha C, Boffa DJ, Detterbeck FC, Kim AW.

Pancreatology. 2015 Sep-Oct;15(5):456-462. doi: 10.1016/j.pan.2015.03.014. Epub 2015 Apr 3. Review.

PMID:
25900320
13.

Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival.

Nicholson AD, Guo X, Sullivan CA, Cha CH.

J Am Coll Surg. 2014 Nov;219(5):977-87. doi: 10.1016/j.jamcollsurg.2014.07.007. Epub 2014 Jul 16.

PMID:
25127509
14.

Hepatocellular carcinoma: a comprehensive overview of surgical therapy.

Fonseca AL, Cha CH.

J Surg Oncol. 2014 Nov;110(6):712-9. doi: 10.1002/jso.23673. Epub 2014 Jun 4. Review.

PMID:
24894746
15.

DKK1 as a serum biomarker for hepatocellular carcinoma.

Prieto PA, Cha CH.

Hepatobiliary Surg Nutr. 2013 Jun;2(3):127-8. doi: 10.3978/j.issn.2304-3881.2012.10.12. No abstract available.

16.

Gastrohepatic fistula as a complication of laparoscopic radiofrequency liver ablation in a patient with intrahepatic cholangiocarcinoma.

Brown C, Chen C, Cha C.

J Clin Gastroenterol. 2014 Jul;48(6):563-4. doi: 10.1097/MCG.0000000000000047. No abstract available.

PMID:
24440942
17.

Surgical therapy for hepatocellular carcinoma: formulating a rational approach.

Cha C.

J Clin Gastroenterol. 2013 Jul;47 Suppl:S30-6. doi: 10.1097/MCG.0b013e31829440bd.

PMID:
23751801
18.

Allergic contact dermatitis associated with Biosyn suture in a patient with gastroesophageal junction cancer.

Kornreich DA, Cha C, Kaley K, Saif MW.

Cutan Ocul Toxicol. 2013 Jun;32(2):166-7. doi: 10.3109/15569527.2012.676120.

PMID:
23153048
19.

Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survival.

Guo X, Schmitz JC, Kenney BC, Uchio EM, Kulkarni S, Cha CH.

Cancer Sci. 2012 Aug;103(8):1474-80. doi: 10.1111/j.1349-7006.2012.02341.x. Epub 2012 Jul 11.

20.

Laparoscopic repair of iatrogenic diaphragmatic hernia following radiofrequency ablation for hepatocellular carcinoma.

Singh M, Singh G, Pandey A, Cha CH, Kulkarni S.

Hepatol Res. 2011 Nov;41(11):1132-6. doi: 10.1111/j.1872-034X.2011.00865.x.

PMID:
22032681
21.

Hepatocellular carcinoma: current management.

Cha CH, Saif MW, Yamane BH, Weber SM.

Curr Probl Surg. 2010 Jan;47(1):10-67. doi: 10.1067/j.cpsurg.2009.09.003. Review. No abstract available.

PMID:
19963083
22.

Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.

Yoo PS, Sullivan CA, Kiang S, Gao W, Uchio EM, Chung GG, Cha CH.

Ann Surg Oncol. 2009 Jan;16(1):200-7. doi: 10.1245/s10434-008-0209-3. Epub 2008 Nov 14.

PMID:
19009247
23.

Minimizing risk in colon and rectal surgery.

Kozol RA, Hyman N, Strong S, Whelan RL, Cha C, Longo WE.

Am J Surg. 2007 Nov;194(5):576-87. Review. No abstract available.

PMID:
17936417
24.

A novel in vitro model of lymphatic metastasis from colorectal cancer.

Yoo PS, Mulkeen AL, Dardik A, Cha CH.

J Surg Res. 2007 Nov;143(1):94-8. Epub 2007 Jul 19.

PMID:
17640671
25.

Venous identity is lost but arterial identity is not gained during vein graft adaptation.

Kudo FA, Muto A, Maloney SP, Pimiento JM, Bergaya S, Fitzgerald TN, Westvik TS, Frattini JC, Breuer CK, Cha CH, Nishibe T, Tellides G, Sessa WC, Dardik A.

Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1562-71. Epub 2007 Apr 26.

PMID:
17463332
26.

Assessing risk factors for adverse outcomes in emergent colorectal surgery.

Yoo PS, Mulkeen AL, Frattini JC, Longo WE, Cha CH.

Surg Oncol. 2006 Aug;15(2):85-9. Epub 2006 Oct 30.

PMID:
17074478
27.

Malnutrition after vascular surgery: are patients with chronic renal failure at increased risk?

Westvik TS, Krause LK, Pradhan S, Westvik HH, Maloney SP, Rutland R, Kudo FA, Muto A, Leite JO, Cha C, Gusberg RJ, Dardik A.

Am J Surg. 2006 Nov;192(5):e22-7.

PMID:
17071176
28.

Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.

Yoo PS, Lopez-Soler RI, Longo WE, Cha CH.

Clin Colorectal Cancer. 2006 Sep;6(3):202-7. Review.

PMID:
17026789
29.

Post-transcriptional regulation of vascular endothelial growth factor: implications for tumor angiogenesis.

Yoo PS, Mulkeen AL, Cha CH.

World J Gastroenterol. 2006 Aug 21;12(31):4937-42. Review.

30.

Safety of carotid endarterectomy in a high-risk population: lessons from the VA and Connecticut.

Weiss JS, Dumas P, Cha C, Gusberg RJ, Dardik A.

J Am Coll Surg. 2006 Sep;203(3):277-82. Epub 2006 Jul 3.

PMID:
16931298
31.

Updates on esophageal and gastric cancers.

Gallo A, Cha C.

World J Gastroenterol. 2006 May 28;12(20):3237-42. Review.

32.

Less common neoplasms of the pancreas.

Mulkeen AL, Yoo PS, Cha C.

World J Gastroenterol. 2006 May 28;12(20):3180-5. Review.

33.

Hospital-based factors predict outcome after carotid endarterectomy.

Westvik HH, Westvik TS, Maloney SP, Kudo FA, Muto A, Leite JO, Gusberg RJ, Cha C, Dardik A.

J Surg Res. 2006 Jul;134(1):74-80. Epub 2006 May 2.

PMID:
16650872
34.

Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells.

Mulkeen AL, Silva T, Yoo PS, Schmitz JC, Uchio E, Chu E, Cha C.

Arch Surg. 2006 Apr;141(4):367-74; discussion 374.

PMID:
16618894
35.

Multiple gastrointestinal stromal tumors and synchronous ileal carcinoids.

Buragas M, Kidd M, Modlin IM, Cha C.

Nat Clin Pract Oncol. 2005 Mar;2(3):166-70; quiz 1 p following 170.

PMID:
16264910
36.

Differential responsiveness of early- and late-passage endothelial cells to shear stress.

Kudo FA, Warycha B, Juran PJ, Asada H, Teso D, Aziz F, Frattini J, Sumpio BE, Nishibe T, Cha C, Dardik A.

Am J Surg. 2005 Nov;190(5):763-9.

PMID:
16226955
37.

Molecular mechanisms in hepatocellular carcinoma development.

Cha C, Dematteo RP.

Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):25-37. Review.

PMID:
15757803
38.

Is there an optimal patient stance for obtaining a lateral 36" radiograph? A critical comparison of three techniques.

Horton WC, Brown CW, Bridwell KH, Glassman SD, Suk SI, Cha CW.

Spine (Phila Pa 1976). 2005 Feb 15;30(4):427-33.

PMID:
15706340
39.

Gastric carcinoid.

Mulkeen A, Cha C.

Curr Opin Oncol. 2005 Jan;17(1):1-6. Review.

PMID:
15608504
40.

Surgical therapy for hepatocellular carcinoma.

Cha C, Dematteo RP, Blumgart LH.

Adv Surg. 2004;38:363-76. Review. No abstract available.

PMID:
15515627
41.

Long-term results with resection of radiation-induced soft tissue sarcomas.

Cha C, Antonescu CR, Quan ML, Maru S, Brennan MF.

Ann Surg. 2004 Jun;239(6):903-9; discussion 909-10.

42.

Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP.

J Am Coll Surg. 2003 Nov;197(5):753-8.

PMID:
14585409
43.

Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation.

Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, DeMatteo RP.

Ann Surg. 2003 Sep;238(3):315-21; discussion 321-3.

44.

Gene therapy applications for spine fusion.

Cha CW, Boden SD.

Spine (Phila Pa 1976). 2003 Aug 1;28(15 Suppl):S74-84. Review.

PMID:
12897478
45.

Surgery and ablative therapy for hepatocellular carcinoma.

Cha C, DeMatteo RP, Blumgart LH.

J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S130-7. Review.

PMID:
12449982
46.

Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration?

Cha C, Chen H, Westra WH, Udelsman R.

Ann Surg Oncol. 2002 Apr;9(3):298-302.

PMID:
11923138
47.

Allogeneic transfusion requirements after autologous donations in posterior lumbar surgeries.

Cha CW, Deible C, Muzzonigro T, Lopez-Plaza I, Vogt M, Kang JD.

Spine (Phila Pa 1976). 2002 Jan 1;27(1):99-104.

PMID:
11805645

Supplemental Content

Loading ...
Support Center